We are live on ! Find out more
GOSS icon

Gossamer Bio
GOSS

74 hedge funds and large institutions have $813M invested in Gossamer Bio in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 11

19% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 21

4% more funds holding

Funds holding: 71 → 74 (+3)

1.19% more ownership

Funds ownership: 54.49% → 55.68% (+1.2%)

5% more capital invested

Capital invested by funds: $776M → $813M (+$36.5M)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
74
Holders Change
+3
Holders Change %
+4.23%
% of All Funds
1.61%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
16
Increased
25
Reduced
21
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$9.58M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$4.88M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$4.37M
4
State Street
State Street
Massachusetts
+$3.73M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$3.7M

Top Sellers

Rank Fund Capital Flow
1
FCM
Farallon Capital Management
California
-$5.32M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.49M
3
MWNA
Marshall Wace North America
New York
-$3.43M
4
MIM
Monashee Investment Management
Massachusetts
-$3.25M
5
SB
Samsara BioCapital
California
-$2.99M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$5.39M +$669K +34,992 +17%
Northern Trust
27
Northern Trust
Illinois
$3.99M +$313K +16,340 +10%
NIP
28
Nicholas Investment Partners
California
$3.18M -$11.6K -607 -0.4%
AA
29
ALPS Advisors
Colorado
$3.06M +$2.64M +137,925 New
Point72 Asset Management
30
Point72 Asset Management
Connecticut
$2.65M +$2.29M +119,673 New
Charles Schwab
31
Charles Schwab
California
$2.39M +$428K +22,368 +26%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$2.33M +$1.04M +54,478 +107%
Alyeska Investment Group
33
Alyeska Investment Group
Illinois
$2.26M -$968K -50,619 -33%
FCM
34
Farallon Capital Management
California
$2.22M -$5.32M -277,852 -74%
N
35
Nuveen
North Carolina
$2.15M +$1.86M +97,069 New
Ameriprise
36
Ameriprise
Minnesota
$1.44M -$17.2K -900 -1%
OAM
37
Oxford Asset Management
United Kingdom
$1.33M -$1.77M -92,473 -61%
UBS Group
38
UBS Group
Switzerland
$1.13M +$972K +50,807 New
FAM
39
Fred Alger Management
New York
$1.11M -$95.7K -5,000 -9%
Swiss National Bank
40
Swiss National Bank
Switzerland
$816K +$704K +36,800 New
TAM
41
Tiverton Asset Management
Delaware
$775K -$158K -8,282 -19%
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$683K +$260K +13,601 +79%
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$633K +$392K +20,500 +254%
FCM
44
Flinton Capital Management
Pennsylvania
$603K -$80.7K -4,216 -13%
Wells Fargo
45
Wells Fargo
California
$568K +$378K +19,778 +341%
EGM
46
Engineers Gate Manager
New York
$534K +$461K +24,092 New
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$523K +$211K +11,046 +88%
TAM
48
Tyers Asset Management
Texas
$497K -$66.4K -3,472 -13%
Deutsche Bank
49
Deutsche Bank
Germany
$431K +$105K +5,513 +39%
Bank of America
50
Bank of America
North Carolina
$412K +$304K +15,882 +599%
1
2
3 4

GOSS Hedge Fund Activity: Q2 2019 in Review

74 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Gossamer Bio (GOSS) for Q2 2019, worth a combined $813M — up 4.7% from $776M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new GOSS positions and 11 closed out — a net gain of 5 holders — while 25 added to existing stakes and 21 trimmed.

The largest buyer was BlackRock, adding an estimated $9.58M. The largest seller was Farallon Capital Management, cutting an estimated $5.32M.

  • 74 institutional investors held Gossamer Bio (GOSS) as of Q2 2019, up from 71 in Q1 2019.
  • Funds reported $813M of Gossamer Bio stock for Q2 2019, up 4.7% quarter-over-quarter.
  • 16 funds opened new Gossamer Bio positions in Q2 2019 and 11 closed out, a net change of +5 holders.
  • The largest Gossamer Bio buyer in Q2 2019 was BlackRock, an estimated $9.58M added.
  • The largest Gossamer Bio seller in Q2 2019 was Farallon Capital Management, an estimated $5.32M sold.

Based on aggregated 13F filings for Q2 2019.